MedTrace Logo

Acupuncture Therapy for COVID-Related Olfactory Loss

NCT04952389 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-03-12

Study results available
· View outcomes & findings →

Summary

This study is looking at the role of acupuncture as a treatment for olfactory dysfunction in patients who tested positive for COVID-19.

Conditions

Interventions

DEVICE

Acupuncture Therapy

Consists of two treatments per week for five weeks

DRUG

Budesonide

Twice daily nasal rinses with steroid medication (budesonide)

OTHER

Olfactory Training

involves smelling 4 different essential oils (e.g. rose, lemon, clove, and eucalyptus) twice a day for 20 seconds each (after the nasal rinse)

Sponsors & Collaborators

Principal Investigators

  • Janalee Stokken, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-07
Primary Completion
2023-04-21
Completion
2023-06-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04952389 on ClinicalTrials.gov